€40m for Treg starver start-upInstitut Curie spin-off Egle Therapeutics has raised €40m in a Series A financing. The company will use the funds to develop First-In-Class T-regulatory cells therapies based on Treg starvers. more ➔
From make-up to jet fuel: Breakthrough for...The French company has taken big steps to scale up its process for converting plant-based feedstocks into isobutene, bringing affordable aviation biofuels into reach. more ➔
Sofinnova Capital X Fund closed at €472mParis-based life sciences venture capital firm Sofinnova Partners has closed the largest early-stage healthcare VC fund in Europe. more ➔
BICO raises €600m and acquires QInstrume...With €600m from a directed share issue in its coffers, BICO finalises the acquisition of QInstruments, a specialist in advanced sample preparation automation. more ➔
European sustainability fund raises €200...The European Circular Bioeconomy Fund, initiated by the EU, has raised more than €200m that will be used to drive the transformation towards a bio-based economy. more ➔
Curevac withdraws MAA of CVnCoVGerman CureVac N.V. has withdrawn its application for market approval of its COVID-19 vaccine candidate and will focus on the development of a second-generation vaccine. more ➔
Idorsia: Failure in Phase IIIBad news for Swiss drug discovery company Idorsia: Its Fabry disease hopeful lucerastat failed to reduce neuropathic pain in patients. more ➔
Delivering on Europe´s Green Deal –... Leading industry leaders, SMEs representatives and academia are joining in Vienna, Austria, at the 14th European Forum for Industrial Biotechnology and the Bioeconomy (EFIB), from 6th to 7th of October, … more ➔
COVID-19 immunisation set to get FDA EUAPharma giant AstraZeneca has submitted data to the US Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its antibody duo AZD7442. more ➔
Thermo Fisher opens Swiss biologics manufa...Lengnau will become the newest site in Thermo Fisher Scientifics biologics manufacturing network. The site is to be completed in 2022 and its staff of 200 will join the company. more ➔
